Ikapharmindo Putramas Tbk. vs Prodia Widyahusada Tbk. — how do they compare? Ikapharmindo Putramas Tbk. trades at Rp183 (market cap 304.92B, 13.7K 24h volume), while Prodia Widyahusada Tbk. trades at Rp2,400 (market cap 2.23T, 351K 24h volume). The key difference: Prodia Widyahusada Tbk. is far larger — about 7.3× Ikapharmindo Putramas Tbk.'s market cap, and Prodia Widyahusada Tbk. is more actively traded (351K versus 13.7K). Which is the better fit depends on your goals.
| IKPM | PRDA | |
|---|---|---|
Market Cap | 304.92B | 2.23T |
Volume | 13.7K | 351K |
Lot | 137 | 3.51K |
Turnover | 2.49M | 842.03M |
Average Price | 181.39 | 2,398.95 |
Value | 2.49M | 842.03M |
Indicative Equilibrium Price | — | 2,400 |
Indicative Equilibrium Volume | — | 65 |
Trailing returns across standard periods
Latest headlines on both assets
PT Ikapharmindo Putramas Tbk (the “Company") was established under the name of PT Ikapharm Indonesia based on Notarial Deed of Lien Tanudirdja, S.H., No. 63 dated May 18, 1978. The Company started its commercial operations in 1978. PT Ikapharma Inti Mas is the Parent Company of the Company.
Read more on IKPM →PT Prodia Widyahusada Tbk (the Company) was established based on the Deed of Notary Sri Rahayu, SH, No. 14 dated February 8, 1988. Clinical Laboratory Prodia was first established in Solo, Central Java, on May 7, 1973 by a few idealists pharmaceutical educational background.
Read more on PRDA →